{"disease":{"id":"stable-angina","name":"stable angina"},"drugs":{"marketed":[{"drug_id":"verapamil-hydrochloride","indication_name":"Chronic stable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."},{"drug_id":"fragmin","indication_name":"Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave MI","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"nicardipine-hydrochloride","indication_name":"Chronic stable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NICARDIPINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Calcium ion channels","drug_class":"Calcium channel blocker","quality_score":53,"revenue":null,"mechanism":"Nicardipine blocks calcium ion influx into vascular smooth muscle, causing relaxation with minimal effect on cardiac muscle."},{"drug_id":"caduet","indication_name":"Chronic Stable Angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Caduet","generic_name":"Amlodipine Besylate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channel","drug_class":"Dihydropyridine calcium channel blocker","quality_score":76,"revenue":null,"mechanism":"Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle."},{"drug_id":"enoxaparin-sodium","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lovenox (Preservative Free)","generic_name":"ENOXAPARIN SODIUM","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Low Molecular Weight Heparin","quality_score":10,"revenue":null,"mechanism":"Lovenox works by enhancing the activity of antithrombin-III to inhibit blood clotting."},{"drug_id":"heparin","indication_name":"Prevention of Cardiac Ischemia in Unstable Angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"HEPARIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Anti-coagulant","quality_score":56,"revenue":null,"mechanism":"Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots."},{"drug_id":"bivalirudin","indication_name":"Unstable Angina Pectoris during PTCA","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Angiomax","generic_name":"BIVALIRUDIN","company_name":"Novartis","drug_phase":"marketed","molecular_target":"thrombin","drug_class":"Anti-coagulant [EPC]","quality_score":10,"revenue":null,"mechanism":"Bivalirudin directly inhibits thrombin by binding to its catalytic site and anion-binding exosite, preventing thrombus formation."},{"drug_id":"verapamil-hydrochloride","indication_name":"Unstable (crescendo, pre-infarction) angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."},{"drug_id":"verapamil-hydrochloride","indication_name":"Chronic stable angina (classic effort-associated angina)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."},{"drug_id":"fragmin","indication_name":"Prophylaxis of ischemic complications in unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"heparin-sodium","indication_name":"Prevention of Cardiac Ischemia in Unstable Angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Heparin Sodium In Plastic Container","generic_name":"Heparin Sodium","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Antithrombin III, Coagulation Factors Xa and IIa","drug_class":"Anticoagulant","quality_score":63,"revenue":null,"mechanism":"Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa."},{"drug_id":"eptifibatide","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Integrilin","generic_name":"EPTIFIBATIDE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Integrin alpha-IIb/beta-3","drug_class":"Platelet Aggregation Inhibitor [EPC]","quality_score":75,"revenue":null,"mechanism":"Integrilin blocks the binding of fibrinogen to platelets, preventing them from clumping together and forming clots."},{"drug_id":"clopidogrel","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Plavix","generic_name":"clopidogrel","company_name":"Generic (originally Sanofi/BMS)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter","drug_class":"Thienopyridine antiplatelet agent","quality_score":55,"revenue":null,"mechanism":"Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis."},{"drug_id":"lovenox","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lovenox","company_name":"University of Monastir","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"enoxaparin","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Enoxaparin","company_name":"Dana-Farber Cancer Institute","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"integrilin","indication_name":"Unstable angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"integrilin","company_name":"University of Cincinnati","drug_phase":"phase_1","molecular_target":"Integrin alpha-IIb/beta-3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":16,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04008173","title":"The International Survey of Acute Coronary Syndromes-ARCHIVES","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":130000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT04097912","title":"Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels","phase":"","overall_status":"COMPLETED","enrollment_count":99999,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07063147","title":"TTE Improves Clinical Management of Stable Chest Pain","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Tianjin Chest Hospital","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT01218776","title":"International Survey of Acute Coronary Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":36000,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT03781492","title":"Stable Angina Management and Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Silesian Centre for Heart Diseases","has_results":false},{"nct_id":"NCT06884436","title":"Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events（MACE）","phase":"","overall_status":"COMPLETED","enrollment_count":22000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05255705","title":"Barts Revascularisation Registry","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT03421873","title":"Effectiveness and Safety of a Clinical Assessment and 0h/1h Troponin Rule-Out Protocol","phase":"","overall_status":"COMPLETED","enrollment_count":16000,"lead_sponsor_name":"Ulf Ekelund","has_results":false},{"nct_id":"NCT04044066","title":"Biomarker-based Prognostic Assessment","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT05719545","title":"A Cohort of Patients Undergoing Percutaneous Coronary Intervention","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Su Guohai","has_results":false},{"nct_id":"NCT07471763","title":"Prospective Lifespan Cohort of Myocardial Infarction","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Fujian Provincial Hospital","has_results":false},{"nct_id":"NCT06075602","title":"COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Luzerner Kantonsspital","has_results":false},{"nct_id":"NCT05631769","title":"HOST - DAPT Duration According the Bleeding Risk","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4900,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05308329","title":"Kitasato PCI Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Kitasato University","has_results":false},{"nct_id":"NCT04718025","title":"Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Collegium Medicum w Bydgoszczy","has_results":false},{"nct_id":"NCT04682756","title":"A Multicenter Study on Early Diagnosis of NSTE-ACS Patients Based on Machine Learning Model","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"First Affiliated Hospital of Xinjiang Medical University","has_results":false},{"nct_id":"NCT02601157","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2173,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03461484","title":"e-BioMatrix 6 Month DAPT France","phase":"","overall_status":"COMPLETED","enrollment_count":2098,"lead_sponsor_name":"Biosensors Europe SA","has_results":false},{"nct_id":"NCT03363035","title":"Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2055,"lead_sponsor_name":"Second Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT03620760","title":"Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":2036,"lead_sponsor_name":"Xiaofan Wu","has_results":false},{"nct_id":"NCT06165406","title":"Distal Radial Access for Coronary Procedures","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Hospital Arnau de Vilanova","has_results":false},{"nct_id":"NCT04988685","title":"SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Luzerner Kantonsspital","has_results":false},{"nct_id":"NCT03752515","title":"A Registry Study on Genetics and Biomarkers of Acute Coronary Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Beijing Institute of Heart, Lung and Blood Vessel Diseases","has_results":false},{"nct_id":"NCT03486561","title":"Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"OBS Pakistan","has_results":false},{"nct_id":"NCT01755520","title":"Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1893,"lead_sponsor_name":"Deutsches Herzzentrum Muenchen","has_results":false},{"nct_id":"NCT04674449","title":"iCorMicA - Stratified Medicine in Angina","phase":"NA","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"NHS Greater Glasgow and Clyde","has_results":false},{"nct_id":"NCT04795505","title":"Effect of Tertiary A-level Hospital Remote Intervention on MACCE, Adherence to Drugs and Risk Factors Control in Patients With Stable Coronary Artery Disease Compared With Traditional Community Hospital Follow-up","phase":"","overall_status":"COMPLETED","enrollment_count":1424,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT03866486","title":"Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study): Retrospective and Prospective Follow-up Study","phase":"","overall_status":"UNKNOWN","enrollment_count":1400,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT03690713","title":"International Collaboration of Comprehensive Physiologic Assessment","phase":"","overall_status":"COMPLETED","enrollment_count":1397,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03338309","title":"INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07444957","title":"Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1118,"lead_sponsor_name":"Fundación Interhospitalaria para la Investigación Cardiovascular FIC","has_results":false},{"nct_id":"NCT05243485","title":"Prehospital Triage of Patients With Suspected Non-ST-segment Elevation Acute Coronary Syndrome: the TRIAGE-ACS Study","phase":"","overall_status":"COMPLETED","enrollment_count":1071,"lead_sponsor_name":"Catharina Ziekenhuis Eindhoven","has_results":false},{"nct_id":"NCT03718559","title":"Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1040,"lead_sponsor_name":"Gi-Byoung Nam","has_results":false},{"nct_id":"NCT03103620","title":"Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry","phase":"","overall_status":"COMPLETED","enrollment_count":1027,"lead_sponsor_name":"CeloNova BioSciences, Inc.","has_results":false},{"nct_id":"NCT04014153","title":"CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?","phase":"","overall_status":"COMPLETED","enrollment_count":1023,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT03755700","title":"Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Rajaie Cardiovascular Medical and Research Center","has_results":false},{"nct_id":"NCT05056662","title":"Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT04810364","title":"HIV Infection And Evolvement of Atherosclerotic Plaque","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Central Clinical Hospital of the Russian Academy of Sciences","has_results":false},{"nct_id":"NCT01881555","title":"Functional Testing Underlying Coronary Revascularisation","phase":"NA","overall_status":"COMPLETED","enrollment_count":941,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04424121","title":"CCTA, CACS and ECG Stress Testing in Patients With Suspected CAD: Precision Phenotyping and Financial Evaluation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"Aristotle University Of Thessaloniki","has_results":false},{"nct_id":"NCT04887571","title":"the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry","phase":"","overall_status":"COMPLETED","enrollment_count":870,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT06464276","title":"Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The V-GOOD Study","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Ministry of Health, Brazil","has_results":false},{"nct_id":"NCT07013344","title":"Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"IRCCS Ospedale San Raffaele","has_results":false},{"nct_id":"NCT05230446","title":"PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions","phase":"NA","overall_status":"RECRUITING","enrollment_count":609,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04144881","title":"Angiographic Control Vs. Ischemia-driven Management of Patients Treated with PCI on Left Main with Drug-eluting Stents","phase":"NA","overall_status":"COMPLETED","enrollment_count":606,"lead_sponsor_name":"A.O.U. Città della Salute e della Scienza","has_results":false},{"nct_id":"NCT06298045","title":"Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diagnosed With Stable Angina and Still Symptomatic Despite First Line Hemodynamic Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Servier Affaires Médicales","has_results":false},{"nct_id":"NCT05865600","title":"Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":570,"lead_sponsor_name":"Gødstrup Hospital","has_results":false},{"nct_id":"NCT04732091","title":"Therapeutic Use of Contrast Ultrasound in Acute Coronary Artery Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06945094","title":"A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":508,"lead_sponsor_name":"Ge Junbo","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}